Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Access via DeepDyve Unlimited fulltext viewing Of this article Organize, annotate And mark up articles Printing And downloading restrictions apply

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: July 12, 2022
Accepted: September 01, 2022
Published online: November 08, 2022

Number of Print Pages: 11
Number of Figures: 4
Number of Tables: 3

ISSN: 0250-8095 (Print)
eISSN: 1421-9670 (Online)

For additional information: https://www.karger.com/AJN

Abstract

Introduction: Metabolic acidosis is associated with chronic kidney disease (CKD) progression and mortality, but the association of race/ethnicity with incident metabolic acidosis and/or its adverse outcomes in patients with CKD is unknown. Methods: We used deidentified medical records data (2007–2019) to generate a cohort of 136,067 patients with nondialysis-dependent CKD stages 3–5 and ≥2 years’ postindex data or death within 2 years. We grouped participants into those with and without metabolic acidosis (serum bicarbonate 12 to <22 mEq/L vs. 22 to <30 mEq/L) as Asian, Black, Hispanic, non-Hispanic White individuals, or unknown. Cox proportional hazards models examined factors associated with (1) incident metabolic acidosis; and (2) time to the composite outcome of death, dialysis, transplant, or ≥40% decline from baseline eGFR (DD40) within each race/ethnic group. Results: Metabolic acidosis incidence was higher for Asian, Black, and Hispanic versus non-Hispanic White individuals (p values for adjusted hazard ratios [HR] all <0.001), but this higher hazard was mitigated in all groups with increasing community education. During the median follow-up of 4.2 years, 47,032 of 136,607 (34.6%) experienced a DD40 event. There was an independent association of metabolic acidosis with DD40 within each race/ethnic group. Adjusted HRs (95% confidence interval) for DD40 were 1.806 (1.312, 2.486), 1.420 (1.313, 1.536), 1.409 (1.211, 1.641), and 1.561 (1.498, 1.626) in Asian, Black, Hispanic, and non-Hispanic White groups, respectively (all p < 0.0001), for metabolic acidosis versus normal serum bicarbonate. Discussion/Conclusion: The higher incidence of metabolic acidosis observed in Asian, Black, and Hispanic individuals was mitigated by residing in higher education zip codes. Once established, metabolic acidosis was independently associated with DD40 in patients with CKD in all racial/ethnic groups examined.

© 2022 S. Karger AG, Basel

References United State Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2019. McCullough KP, Morgenstern H, Saran R, Herman WH, Robinson BM. Projecting ESRD incidence and prevalence in the United States through 2030. J Am Soc Nephrol. 2019;30(1):127–35. Bowe B, Xie Y, Li T, Mokdad AH, Xian H, Yan Y, et al. Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the Global Burden of Disease study. JAMA Netw Open. 2018;1(7):e184412. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts. Kidney Int. 2011;79(12):1341–52. Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DMJ, et al. Past decline versus current eGFR and subsequent ESRD risk. J Am Soc Nephrol. 2016;27(8):2447–55. Naimark DMJ, Grams ME, Matsushita K, Black C, Drion I, Fox CS, et al. Past decline versus current eGFR and subsequent mortality risk. J Am Soc Nephrol. 2016;27(8):2456–66. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14(11):2902–7. Krop JS, Coresh J, Chambless LE, Shahar E, Watson RL, Szklo M, et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the atherosclerosis risk in Communities study. Arch Intern Med. 1999;159(15):1777–83. Raphael KL, Wei G, Baird BC, Greene T, Beddhu S. Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney Int. 2011;79(3):356–62. Shah SN, Abramowitz M, Hostetter TH, Melamed ML. Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis. 2009;54(2):270–7. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM. Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol. 2009;20(9):2075–84. Di Iorio BR, Bellasi A, Raphael KL, Santoro D, Aucella F, Garofano L, et al. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI study. J Nephrol. 2019;32(6):989–1001. Goraya N, Simoni J, Jo CH, Wesson DE. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate. Kidney Int. 2014;86(5):1031–8. Phisitkul S, Khanna A, Simoni J, Broglio K, Sheather S, Rajab MH, et al. Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR. Kidney Int. 2010;77(7):617–23. Tangri N, Grams ME, Levey AS, Coresh J, Appel LJ, Astor BC, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis. JAMA. 2016;315(2):164–74. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011;305(15):1553–9. Tangri N, Reaven NL, Funk SE, Ferguson TW, Collister D, Mathur V. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study. BMC Nephrol. 2021;22(1):185. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013 Jan;3(1). Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O’Hare AM. White/Black racial differences in risk of end-stage renal disease and death. Am J Med. 2009;122(7):672–8. Peralta CA, Katz R, DeBoer I, Ix J, Sarnak M, Kramer H, et al. Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol. 2011;22(7):1327–34. Hsu CY, Chertow GM. Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant. 2002;17(8):1419–25. Moranne O, Froissart M, Rossert J, Gauci C, Boffa JJ, Haymann JP, et al. Timing of onset of CKD-related metabolic complications. J Am Soc Nephrol. 2009;20(1):164–71. Wesson DE. The continuum of acid stress. Clin J Am Soc Nephrol. 2021;16(8):1292–9. Adeva MM, Souto G. Diet-induced metabolic acidosis. Clin Nutr. 2011;30(4):416–21. Remer T. Influence of nutrition on acid-base balance: metabolic aspects. Eur J Nutr. 2001;40(5):214–20. Goraya N, Simoni J, Jo CH, Wesson DE. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate. Clin J Am Soc Nephrol. 2013;8(3):371–81. Moore LV, Thompson FE. Adults meeting fruit and vegetable intake recommendations: United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(26):709–13. Fernandes AS, Ramos CI, Nerbass FB, Cuppari L. Diet quality of chronic kidney disease patients and the impact of nutritional counseling. J Ren Nutr. 2018;28(6):403–10. Guerrero AD, Chung PJ. Racial and ethnic disparities in dietary intake among California children. J Acad Nutr Diet. 2016;116(3):439–48. Lee-Kwan SH, Moore LV, Blanck HM, Harris DM, Galuska D. Disparities in state-specific adult fruit and vegetable consumption: United States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(45):1241–7. McCullough ML, Chantaprasopsuk S, Islami F, Rees-Punia E, Um CY, Wang Y, et al. Association of socioeconomic and geographic factors with diet quality in US adults. JAMA Netw Open. 2022;5(6):e2216406. Dubowitz T, Heron M, Bird CE, Lurie N, Finch BK, Basurto-Davila R, et al. Neighborhood socioeconomic status and fruit and vegetable intake among Whites, Blacks, and Mexican Americans in the United States. Am J Clin Nutr. 2008;87(6):1883–91. Dai CL, Sharma M, Haider T, Sunchu H. Fruit and vegetable consumption behavior among Asian Americans: a thematic analysis. J Prim Care Community Health. 2021;12:2150132720984776. Zambrana RE, Williams DR. The intellectual roots of current knowledge on racism and health: relevance to policy and the national equity discourse. Health Aff. 2022;41(2):163–70. Gosliner W, Brown DM, Sun BC, Woodward-Lopez G, Crawford PB. Availability, quality, and price of produce in low-income neighbourhood food stores in California raise equity issues. Public Health Nutr. 2018;21(9):1639–48. Article / Publication Details

First-Page Preview

Received: July 12, 2022
Accepted: September 01, 2022
Published online: November 08, 2022

Number of Print Pages: 11
Number of Figures: 4
Number of Tables: 3

ISSN: 0250-8095 (Print)
eISSN: 1421-9670 (Online)

For additional information: https://www.karger.com/AJN